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METHOD: Inappropriate geriatric medications were
deﬁned by well accepted explicit criteria. Logistic models
were employed to estimate the likelihood functions using
the 1996 Medical Expenditure Panel Survey (MEPS),
based on a national representative sample of the non-
institutionalized populations. Complex survey sample
design was adjusted in modeling.
RESULTS: When grouping all types of insurance together,
a dichotomous insurance variable captured no difference
in the likelihood of inappropriate medication use between
the insured and the uninsured groups. After distinguish-
ing the insurance type, it was found that the elderly 
with fee-for-service (FFS) coverage were more likely to 
use inappropriate prescriptions (OR = 1.73, 95% CI:
1.27–2.34), compared to those without coverage. This
effect was reduced but remained signiﬁcant after control-
ling for the total number of prescriptions (OR = 1.39,
95% CI: 1.01–1.90). In contrast, people with HMO type
of coverage were indifferent with the uninsured. More-
over, as expected, the most predictive variable of inap-
propriate prescriptions is the total number of medication
use, followed by worse health conditions and women.
CONCLUSION: When analyzing insurance impact on
drug utilization, distinguishing insurance type seemed to
be important. This study suggested a higher risk with FFS
model for inappropriate medication use compared to the
uninsured and others, the ﬁrst evidence of its kind based
on a national database. While this ﬁnding offers some
interesting implications for insurance policies, further
research is warranted to discern the reasons for the
observed adverse impact of FFS coverage.
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OBJECTIVE: The general practitioner is often the ﬁrst
professional involved in the treatment of tobacco depen-
dence, when he or she responds to the explicit request of
smokers to help end their tobacco consumption or asks
his or her patients about their situation in relation to
tobacco.
METHOD: The STOP programme, through a ques-
tionnaire distributed to around 6,000 doctors, aims to
describe the progress doctors are making with regard to
their own tobacco dependence as well as in the public
health initiative entrusted to them.
RESULTS: Here we present the preliminary results of this
investigation, through the analysis of the ﬁrst 300 ques-
tionnaires. The average age of our sample was 45 years;
75% were men. For 41% of the doctors that responded,
the setting up of a treatment programme takes place
during a speciﬁc consultation. The information supports
used come from the pharmaceutical industry (62%),
health insurance companies and anti-smoking associa-
tions (38%). 82% felt that the most relevant support was
patient information that they could distribute and that
would back up verbal advice. If 51% of doctors state that
they have never smoked, 62% of the smokers expressed
a desire to give up smoking, and 85% of them do not
consider their status as smokers as a hindrance to begin-
ning smoking cessation treatment with their patients.
Lack of training (3%), skepticism as to the effectiveness
of available treatments (4%), the absence of speciﬁc
remuneration (4%), do not seem to be the reasons for 
not beginning smoking cessation treatment with their
patients, unlike lack of time (49%) and patient resistance
(41%).
CONCLUSION: First professional involved, the general
practitioner should thus be recognised as a real partner
in Health policy and improve their commitment with it.
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Positive clinical outcomes are dependent on patients
adhering to their treatment plans. Improving patients’
medication compliance through a mail-based medication
support program that promotes preferred formulary
agents leads to improved clinical outcomes. It also results
in a win-win-win situation for patients, payers and indus-
try partners by increasing appropriate and cost-effective
utilization.
OBJECTIVES: This study assesses the effectiveness of 
a mail-based medication support program designed to
increase prescription reﬁll rates for selected maintenance
medications. All patients taking selected medications 
are sent a welcome package. Patients late in reﬁlling their
prescriptions are sent a reminder letter. Patients who do
not reﬁll are sent a second reminder letter. Patients 
who remain non-compliant may be called by a nurse case
manager. Patients who reﬁll a new prescription on a
timely basis are sent a congratulations letter.
METHODS: In phase one, reﬁll rates for patients receiv-
ing one or more reﬁll reminder letters are compared with
the reﬁll rates for a comparison sample of patients who
did not receive reminder letters. In phase two, to be com-
pleted Q1 2002, we will compare the reﬁll rates and cost
proﬁles between selected medications and a similar class
of unselected medications.
RESULTS: Phase one results show that patients who
received reminder letters proceeded to have 14,731 ﬁlls,
537,321 units for 431,200 days supply. This compares to
the control group, which had 10,329 ﬁlls, 376,736 units
for 302,331 days supply. The difference between the
groups shows that the intervention produced 4,403 ﬁlls,
160,585 units for 128,870 days supply.
CONCLUSIONS: Initial results show that a mail-based
medication reﬁll reminder program is an effective means
